Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

MBD3/NuRD loss participates with KDM6A program to promote DOCK5/8 expression and Rac GTPase activation in human acute myeloid leukemia.

Biswas M, Chatterjee SS, Boila LD, Chakraborty S, Banerjee D, Sengupta A.

FASEB J. 2019 Apr;33(4):5268-5286. doi: 10.1096/fj.201801035R. Epub 2019 Jan 22.

PMID:
30668141
2.

A Potent Conformation-Constrained Synthetic Peptide Mimic of a Homeodomain Selectively Regulates Target Genes in Cells.

Ghosh B, Boila LD, Choudhury S, Mondal P, Bhattacharjee S, Pal SK, Sengupta A, Roy S.

ACS Chem Biol. 2018 Aug 17;13(8):2003-2009. doi: 10.1021/acschembio.8b00488. Epub 2018 Jul 16.

PMID:
29966078
3.

SMARCB1 Deficiency Integrates Epigenetic Signals to Oncogenic Gene Expression Program Maintenance in Human Acute Myeloid Leukemia.

Chatterjee SS, Biswas M, Boila LD, Banerjee D, Sengupta A.

Mol Cancer Res. 2018 May;16(5):791-804. doi: 10.1158/1541-7786.MCR-17-0493. Epub 2018 Feb 26.

4.

KDM6 and KDM4 histone lysine demethylases emerge as molecular therapeutic targets in human acute myeloid leukemia.

Boila LD, Chatterjee SS, Banerjee D, Sengupta A.

Exp Hematol. 2018 Feb;58:44-51.e7. doi: 10.1016/j.exphem.2017.10.002. Epub 2017 Oct 27.

PMID:
29111428

Supplemental Content

Loading ...
Support Center